Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Selling, general, and administrative expenses
3Y CAGR
-6.4%/yr
vs -2.3%/yr prior
5Y CAGR
+3.5%/yr
Recent deceleration
Acceleration
-4.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.46M | +1.6% |
| 2024 | $18.17M | +5.0% |
| 2023 | $17.30M | -23.1% |
| 2022 | $22.51M | +23.6% |
| 2021 | $18.21M | +17.0% |
| 2020 | $15.57M | -35.2% |
| 2019 | $24.03M | -2.8% |
| 2018 | $24.73M | +24.1% |
| 2017 | $19.92M | -29.9% |
| 2016 | $28.43M | - |